Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| GLUT4 | P14672 | Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) | Disease related genesMetabolic proteinsPotential drug targets | 12 | Diabetes mellitusType 2 diabetes mellitus | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.40 | ||
| MRC1 | P22897 | Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) | CD markersFDA approved drug targetsPlasma proteins | 1 | COVID-19Type 2 diabetes mellitus | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 5 | 0.40 | ||
| PCDG6 | Q9Y5G7 | Protocadherin gamma-A6 (PCDH-gamma-A6) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 5 | 0.40 | |||
| PCDG8 | Q9Y5G5 | Protocadherin gamma-A8 (PCDH-gamma-A8) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 5 | 0.40 | |||
| PRRT2 | Q7Z6L0 | Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3) | Disease related genesHuman disease related genesPotential drug targets | 1 | DystoniaEpilepsy | Fusion and delivery mediationReceptor-signaling mediation | 5 | 0.40 | ||
| S19A1 | P41440 | Reduced folate transporter (FOLT) (Cyclic dinucleotide:anion antiporter SLC19A1) (Folate:anion antiporter SLC19A1) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (hRFC) (Reduced folate transporter 1) (RFT-1) (Solute carrier family 19 member 1) (hSLC19A1) | Cancer-related genesDisease related genesMetabolic proteins | 12 | Hereditary hemolytic anemiaFolate deficiency anaemiaLeukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.40 | ||
| S26A2 | P50443 | Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2) | Disease related genesHuman disease related genesMetabolic proteins | 8 | Dwarfism | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.40 | ||
| S38A5 | Q8WUX1 | Sodium-coupled neutral amino acid transporter 5 (Solute carrier family 38 member 5) (System N transporter 2) | Metabolic proteinsPredicted membrane proteinsTransporters | 11 | Fusion and delivery mediation | 5 | 0.40 | |||
| S4A8 | Q2Y0W8 | Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3) | 11 | Fusion and delivery mediation | 5 | 0.40 | ||||
| SCN7A | Q01118 | Sodium channel protein type 7 subunit alpha (Atypical sodium channel Nav2.1) (Nax channel) (Sodium channel protein type VII subunit alpha) | FDA approved drug targetsMetabolic proteinsPlasma proteins | 24 | Clinical-translation mediationFusion and delivery mediation | 5 | 0.40 |